Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by jfm1330


T.TH

RE:RE:RE:RE:RE:RE:RE:Best Case Scenario

I have a hard time to believe that they are still enrolling one patient per...

January 18, 2022

T.TH

RE:RE:RE:RE:RE:For anybody interested in the CYDY story

I agree CYDY is a very bad example, but the Sutro comparison shows that Thera...

January 13, 2022

T.TH

RE:RE:RE:RE:RE:For anybody interested in the CYDY story

You know that better than me but CYDY is working on a particular segment of...

January 13, 2022

T.TH

RE:RE:RE:For anybody interested in the CYDY story

It would be fitting to see CYDY back to where it belongs because it is an...

January 13, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:Here it is!

Sorry but there is at least one who did not bite on that. But as you said, I...

January 11, 2022

T.TH

RE:RE:RE:RE:RE:RE:Covid implications for meetings with shareholders

Don't take it badly, but this is a very American question... I agree...

January 11, 2022

T.TH

RE:RE:RE:RE:Covid implications for meetings with shareholders

I found the reference used by Thera for the studu design on clinicaltrials...

January 10, 2022

T.TH

RE:RE:RE:Covid implications for meetings with shareholders

Not strident enough, hospitals are overwhelmed, deaths are on a sharp rise...

January 9, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Something big is likely in the works

You assume that a better deal was obviously possible, but there is no proof...

January 9, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Something big is likely in the works

The myth of the supposedly awful financing is perpetuated here. It was...

January 9, 2022

T.TH

RE:RE:RE:Something big is likely in the works

I don't know if you remember, but Marsolais said in a recent CC that they...

January 7, 2022

T.TH

RE:RE:RE:CYDY

The oddity is Cytodyn, not Thera. If Thera get excellent results in oncology...

January 7, 2022

T.TH

RE:RE:RE:RE:Something big is likely in the works

Yeah, Paul, the guy who decided to buy Katana. Oh wait! Sorry it was Luc... ...

January 7, 2022

T.TH

RE:CYDY

0.70$ today, less than a year ago it was at 7.15$. So much for "...

January 7, 2022

T.TH

RE:RE:Something big is likely in the works

Funny to read that. All those complaints on how bad this company is at almost...

January 7, 2022

T.TH

RE:Something big is likely in the works

Never sure of anything, but this makes sense. Add to that a lot of hiring for...

January 7, 2022

T.TH

RE:Corporate Presentation's absence

Top insiders at Thera are aware since a while of important informations that...

January 6, 2022

T.TH

Linkedin

A new Thera post on Linkedin was like by a guy working for HE Capital Markets...

January 6, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Possible chinese partner?

Many here should simply sell and move on. Go after the Cytodyns of this world...

January 4, 2022

T.TH

RE:RE:RE:New year

Obviously not would but could All that is false, Levesque clearly stated...

January 3, 2022

Featured Company